4
Changes in Ownership
Silence Therapeutics plc Filed Acc 0001415889-25-000744
Options or other derivatives
- Chief Financial Officer acquired 375,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| HELLUMS RHONDA LYNETTE Chief Financial Officer | 2025-01-02 | Grant or award · Employee Share Option (Right to Buy) | +375,000 | 375,000 | D | ||
Loading xslF345X05/form4-01062025_040104.xml…